The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

M.N. Kalinin

Kazan State Medical University;
Interregional Clinical Diagnostic Center

D.R. Khasanova

Kazan State Medical University;
Interregional Clinical Diagnostic Center

Cerebrolysin as an early add-on to reperfusion therapy: heterogeneous treatment effect analysis in ischemic stroke patients with varying risk of hemorrhagic transformation

Authors:

M.N. Kalinin, D.R. Khasanova

More about the authors

Views: 526

Downloaded: 15


To cite this article:

Kalinin MN, Khasanova DR. Cerebrolysin as an early add-on to reperfusion therapy: heterogeneous treatment effect analysis in ischemic stroke patients with varying risk of hemorrhagic transformation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(3‑2):55‑66. (In Russ.)
https://doi.org/10.17116/jnevro202412403255

Recommended articles:
Multimodal technology in the correction of post-stroke motor diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3-2):58-67
Social and economic burden of stroke in Russian Fede­ration. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(8-2):5-15
Cere­brolysin in the treatment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):20-25
Modern view on upper limb physical reha­bilitation after stroke. Lite­rature review. Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(1):42-53
Moyamoya disease and syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(6):7-15

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.